首页> 外国专利> N-(2,2,2-Trihalo-1-(thia)morpholino-ethyl)-carbamates or-formamides - prepd by reacting (thia)morpholines with N-(1,2,2,2-tetrahaloethyl) cpds

N-(2,2,2-Trihalo-1-(thia)morpholino-ethyl)-carbamates or-formamides - prepd by reacting (thia)morpholines with N-(1,2,2,2-tetrahaloethyl) cpds

机译:N-(2,2,2-Trihalo-1-(thia)morpholino-ethyl)-carbamates or-formamides-通过使(thia)morpholines与N-(1,2,2,2-tetrahaloethyl)cpds反应来制备

摘要

Carbamates or formamides of formula (I) (where R1 is H or 1-8C alkoxy; X1 is H, Cl or Br; X2 and X3 are Cl or Br; Y is O or S; R is 1-4C alkyl and/or phenyl; and n is 1,2 or 3; provided that when n is 2 the two R's are not both methyl or both phenyl, or the two R's are methyl in the 2,2-, 2,5- or 2,6-position), e.g. N-(1-formamido-2,2,2-trichloroethyl)-2,6-dimethylmorpholine or N-(1-ethoxycarbonylamino-2,2,2-trichloroethyl)-2,6-dimethylmorpho- line, and their pharmacologically tolerable salts are new cpds. (I) have sedative, hypnotic, narcotic and anticonvulsant activity and can be used e.g. in the treatment of sleep disorders; dosage is 100-200 mg. Results of pharmacological tests are given in the specification; thus, 4-(1-formamido-2,2,2-trichloroethyl)2-methyl-morpholine in a dosage of 46.4, 100 or 215mg/kg p. o gives a lowering of rat body temperature of 1.82, 2.00 or 3.07 degrees C, resp. (lowering of body temp. is a measure of sedative and narcotic activity).
机译:式(I)的氨基甲酸酯或甲酰胺(其中R 1为H或1-8C烷氧基; X 1为H,Cl或Br; X 2和X 3为Cl或Br; Y为O或S; R为1-4C烷基和/或苯基;并且n为1,2或3;前提是当n为2时,两个R既不是甲基也不是苯基,也不是两个苯基,或者两个R都不是2,2-,2,5-或2,6-的甲基位置),例如N-(1-甲酰胺基-2,2,2-三氯乙基)-2,6-二甲基吗啉或N-(1-乙氧羰基氨基-2,2,2-三氯乙基)-2,6-二甲基吗啉及其药理学耐受性盐是新的cpds。 (I)具有镇静,催眠,麻醉和抗惊厥活性,可用于例如在治疗睡眠障碍;剂量是100-200毫克。说明书中给出了药理试验的结果;因此,4-(1-甲酰胺基-2,2,2-三氯乙基)2-甲基吗啉的剂量为46.4、100或215mg / kg p。 o分别将大鼠的体温降低了1.82、2.00或3.07摄氏度。 (降低体温是镇静和麻醉活性的量度)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号